Vaishali Pharma Limited (VAISHALI.NS)

INR 12.21

(-0.41%)

EBITDA Summary of Vaishali Pharma Limited

  • Vaishali Pharma Limited's latest annual EBITDA in 2023 was 31.71 Million INR , down -89.99% from previous year.
  • Vaishali Pharma Limited's latest quarterly EBITDA in 2024 Q1 was 23.44 Million INR , up 147.12% from previous quarter.
  • Vaishali Pharma Limited reported an annual EBITDA of 113.59 Million INR in 2022, up 30.95% from previous year.
  • Vaishali Pharma Limited reported an annual EBITDA of 86.43 Million INR in 2021, up 38.16% from previous year.
  • Vaishali Pharma Limited reported a quarterly EBITDA of 29.54 Million INR for 2023 Q2, up 10.69% from previous quarter.
  • Vaishali Pharma Limited reported a quarterly EBITDA of 29.52 Million INR for 2023 Q3, down -0.06% from previous quarter.

Annual EBITDA Chart of Vaishali Pharma Limited (2023 - 2012)

Historical Annual EBITDA of Vaishali Pharma Limited (2023 - 2012)

Year EBITDA EBITDA Growth
2023 31.71 Million INR -89.99%
2022 113.59 Million INR 30.95%
2021 86.43 Million INR 38.16%
2020 44.42 Million INR -13.3%
2019 29.99 Million INR 80.43%
2018 40.4 Million INR -9.88%
2017 44.52 Million INR 1.56%
2016 44.09 Million INR 17.5%
2015 37.31 Million INR -6.11%
2014 39.74 Million INR 19.21%
2013 33.33 Million INR 79.39%
2012 18.58 Million INR 0.0%

Peer EBITDA Comparison of Vaishali Pharma Limited

Name EBITDA EBITDA Difference
Alembic Pharmaceuticals Limited 9.61 Billion INR 99.67%
Hester Biosciences Limited 539.47 Million INR 94.122%
Aarti Drugs Limited 3.24 Billion INR 99.024%
Aarti Pharmalabs Limited 3.9 Billion INR 99.189%
Albert David Limited 1.04 Billion INR 96.967%
Alembic Limited 1.11 Billion INR 97.159%
Alkem Laboratories Limited 24.19 Billion INR 99.869%
Bafna Pharmaceuticals Limited 114.58 Million INR 72.325%
Bajaj HealthCare Limited 406.23 Million INR 92.194%
Biofil Chemicals and Pharmaceuticals Limited 12.99 Million INR -144.006%
Brooks Laboratories Limited 41.72 Million INR 24.005%
Eris Lifesciences Limited 6.98 Billion INR 99.546%
FDC Limited 3.38 Billion INR 99.063%
Glenmark Life Sciences Limited 6.86 Billion INR 99.538%
Gufic Biosciences Limited 1.48 Billion INR 97.858%
Hikal Limited 2.69 Billion INR 98.822%
Ind-Swift Limited 1.06 Billion INR 97.023%
Innova Captab Limited 1.66 Billion INR 98.099%
IOL Chemicals and Pharmaceuticals Limited 2.6 Billion INR 98.783%
Jagsonpal Pharmaceuticals Limited 323.46 Million INR 90.196%
Jubilant Pharmova Limited 8 Billion INR 99.604%
Lincoln Pharmaceuticals Limited 1.34 Billion INR 97.639%
Lupin Limited 36.96 Billion INR 99.914%
Mangalam Drugs & Organics Limited 174.94 Million INR 81.874%
Medico Remedies Limited 129.09 Million INR 75.436%
Morepen Laboratories Limited 1.72 Billion INR 98.163%
Nectar Lifesciences Limited 1.53 Billion INR 97.935%
Orchid Pharma Limited 1.41 Billion INR 97.766%
Procter & Gamble Health Limited 3.07 Billion INR 98.969%
RPG Life Sciences Limited 1.28 Billion INR 97.525%
Kilitch Drugs (India) Limited 287.42 Million INR 88.967%
Sigachi Industries Limited 883.39 Million INR 96.41%
Solara Active Pharma Sciences Limited -2.82 Billion INR 101.124%
Suven Pharmaceuticals Limited 4.67 Billion INR 99.322%
Themis Medicare Limited 562.6 Million INR 94.364%
Unichem Laboratories Limited 742.35 Million INR 95.728%
Wanbury Limited 985.49 Million INR 96.782%
Windlas Biotech Limited 781.72 Million INR 95.943%
ZIM Laboratories Limited 462.09 Million INR 93.138%
Ind-Swift Laboratories Limited 6.86 Billion INR 99.538%
Ipca Laboratories Limited 13.29 Billion INR 99.762%
Sun Pharmaceutical Industries Limited 138.36 Billion INR 99.977%
Venus Remedies Limited 711.8 Million INR 95.545%
Sakar Healthcare Limited 393.26 Million INR 91.937%
Aurobindo Pharma Limited 61.78 Billion INR 99.949%
Divi's Laboratories Limited 25.43 Billion INR 99.875%
AstraZeneca Pharma India Limited 2.35 Billion INR 98.654%
Mankind Pharma Limited 28.09 Billion INR 99.887%
Sequent Scientific Limited 549.8 Million INR 94.232%
Laurus Labs Limited 8 Billion INR 99.604%
Neuland Laboratories Limited 4.74 Billion INR 99.332%
J. B. Chemicals & Pharmaceuticals Limited 9.33 Billion INR 99.66%
Glenmark Pharmaceuticals Limited 11.34 Billion INR 99.72%
Zydus Lifesciences Limited 56.22 Billion INR 99.944%
Amrutanjan Health Care Limited 681.59 Million INR 95.348%
Wockhardt Limited 1.08 Billion INR 97.064%
Bal Pharma Limited 345.59 Million INR 90.824%
Dr. Reddy's Laboratories Limited 88.27 Billion INR 99.964%
Bliss GVS Pharma Limited 1.47 Billion INR 97.856%
Par Drugs and Chemicals Limited 228.17 Million INR 86.102%
Caplin Point Laboratories Limited 6.18 Billion INR 99.487%
Shilpa Medicare Limited 2.58 Billion INR 98.775%
Valiant Laboratories Limited 12.73 Million INR -148.928%
Ajanta Pharma Limited 12.56 Billion INR 99.748%
Aarey Drugs & Pharmaceuticals Limited 45.16 Million INR 29.789%
Granules India Limited 8.6 Billion INR 99.631%
Medicamen Biotech Limited 245.66 Million INR 87.092%
Syncom Formulations (India) Limited 430.27 Million INR 92.63%
Piramal Enterprises Limited -3.86 Billion INR 100.821%
Torrent Pharmaceuticals Limited 35 Billion INR 99.909%
NATCO Pharma Limited 18.79 Billion INR 99.831%
Suven Life Sciences Limited -992.78 Million INR 103.194%
Krebs Biochemicals & Industries Limited -82.72 Million INR 138.332%
Strides Pharma Science Limited 3.76 Billion INR 99.158%
Indoco Remedies Limited 2.64 Billion INR 98.802%
Alpa Laboratories Limited 229.96 Million INR 86.21%
Lasa Supergenerics Limited -65.08 Million INR 148.726%
Sun Pharma Advanced Research Company Limited -3.73 Billion INR 100.85%